Issue 10 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

33

No.

10

March 16, 2007Mar 16, 2007

Free

DOWNLOAD THE PDF

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026